Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,156 GBX | -0.73% | -0.80% | +14.77% |
10:04am | ASTRAZENECA : UBS reiterates its Sell rating | ZD |
14/05 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 239B | |
+30.65% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+9.79% | 210B | |
-7.36% | 200B | |
+8.12% | 167B | |
-1.42% | 161B | |
+1.70% | 124B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Deutsche Bank keeps a Sell rating